Chargement en cours...
Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence
Progress in the treatment of patients with advanced stage squamous cell non-small cell lung cancer (NSCLC) has been limited. An improvement in the understanding of tumor immunosurveillance has resulted in the development of the immune checkpoint inhibitors such as nivolumab. Nivolumab (Opdivo(®)), a...
Enregistré dans:
| Publié dans: | Ther Adv Respir Dis |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933620/ https://ncbi.nlm.nih.gov/pubmed/27480166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465816661091 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|